540 related articles for article (PubMed ID: 12893883)
1. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
[TBL] [Abstract][Full Text] [Related]
2. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
[TBL] [Abstract][Full Text] [Related]
4. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts.
Thompson PD; Remus LS; Hsieh JC; Jurutka PW; Whitfield GK; Galligan MA; Encinas Dominguez C; Haussler CA; Haussler MR
J Mol Endocrinol; 2001 Oct; 27(2):211-27. PubMed ID: 11564604
[TBL] [Abstract][Full Text] [Related]
5. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor.
Prüfer K; Barsony J
Mol Endocrinol; 2002 Aug; 16(8):1738-51. PubMed ID: 12145331
[TBL] [Abstract][Full Text] [Related]
6. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
[TBL] [Abstract][Full Text] [Related]
7. The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation.
Solomon C; Macoritto M; Gao XL; White JH; Kremer R
J Bone Miner Res; 2001 Jan; 16(1):39-45. PubMed ID: 11149488
[TBL] [Abstract][Full Text] [Related]
8. Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription.
Pike JW; Pathrose P; Barmina O; Chang CY; McDonnell DP; Yamamoto H; Shevde NK
J Cell Biochem; 2003 Feb; 88(2):252-8. PubMed ID: 12520523
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1).
Castillo AI; Jimenez-Lara AM; Tolon RM; Aranda A
Mol Endocrinol; 1999 Jul; 13(7):1141-54. PubMed ID: 10406465
[TBL] [Abstract][Full Text] [Related]
11. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor.
Liu YY; Nguyen C; Peleg S
Mol Endocrinol; 2000 Nov; 14(11):1776-87. PubMed ID: 11075811
[TBL] [Abstract][Full Text] [Related]
12. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
Tagami T; Lutz WH; Kumar R; Jameson JL
Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators.
Issa LL; Leong GM; Sutherland RL; Eisman JA
J Bone Miner Res; 2002 May; 17(5):879-90. PubMed ID: 12009019
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D represses retinoic acid-dependent transactivation of the retinoic acid receptor-beta2 promoter: the AF-2 domain of the vitamin D receptor is required for transrepression.
Jiménez-Lara AM; Aranda A
Endocrinology; 1999 Jun; 140(6):2898-907. PubMed ID: 10342883
[TBL] [Abstract][Full Text] [Related]
17. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo.
Lemon BD; Freedman LP
Mol Cell Biol; 1996 Mar; 16(3):1006-16. PubMed ID: 8622645
[TBL] [Abstract][Full Text] [Related]
18. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
[TBL] [Abstract][Full Text] [Related]
19. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation.
Matkovits T; Christakos S
Mol Endocrinol; 1995 Feb; 9(2):232-42. PubMed ID: 7776973
[TBL] [Abstract][Full Text] [Related]
20. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
Kephart DD; Walfish PG; DeLuca H; Butt TR
Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]